feb-2007 [email protected] 1 cpmp/ewp/1776/99: ptc on missing data

Feb-2007Feb-2007 [email protected]@uab.es 11

CPMP/EWP/1776/99: CPMP/EWP/1776/99:

PtC on Missing DataPtC on Missing Data


Evolución de los sujetosEvolución de los sujetos

PACVisita

SelecciónVisitaBasal RND

Toma de 1a.Medicación Visita 1 Visita 2 Visita 3 Visita 4

1 X X A X X X X X

2 X X A

3 X X B X X X

4 X X A X

5 X X B X X X X/A @ X/A @

6 X X B X X

7 X X A X X X X

8 X

9 X X B X X X X X

10 X X B X X/ERR. X X X


Datos faltantes (missing data)Datos faltantes (missing data)(1)(1)

¿Qué son los datos faltantes? ¡¡¡¡¡ Casillas vacías ¿Qué son los datos faltantes? ¡¡¡¡¡ Casillas vacías en los CRDs!!! en los CRDs!!!

Viola el principio de la estricto principio de la ITTViola el principio de la estricto principio de la ITT La posibles causas son, por ejemplo :La posibles causas son, por ejemplo :

– Pérdida de seguimientoPérdida de seguimiento– Fracaso o éxito terapéuticoFracaso o éxito terapéutico– Acontecimiento adversoAcontecimiento adverso– Traslado del sujetoTraslado del sujeto

No todas las razones de abandono están No todas las razones de abandono están relacionadas con el tratamientorelacionadas con el tratamiento


Datos faltantes (missing data) Datos faltantes (missing data) (2)(2)

Afectando a :Afectando a :– Solo un datoSolo un dato– Varios datos en una visitaVarios datos en una visita– Toda una visitaToda una visita– Varias visitasVarias visitas– Toda una variableToda una variable– Todas las visitas tras la inclusiónTodas las visitas tras la inclusión


Datos faltantes (missing data) Datos faltantes (missing data) (3)(3)

Por qué son un problema? Potencial fuente Por qué son un problema? Potencial fuente de sesgos en el análisisde sesgos en el análisis

– Tanto mayor cuanto mayor la proporción de datos Tanto mayor cuanto mayor la proporción de datos

afectadosafectados– Tanto más sesgo cuanto menos aleatoriosTanto más sesgo cuanto menos aleatorios– Tanta más interferencia cuanto más relacionados con el Tanta más interferencia cuanto más relacionados con el

tratamientotratamiento– Impide la ITTImpide la ITT


EJEMPLOSEJEMPLOS


Ejemplo: Descripción de poblaciones (1)Ejemplo: Descripción de poblaciones (1)Distribución de pacientes :

All-randomizedAll-randomized

Patients with a Patients with a randomization randomization codecode

1208 1208 (100%)(100%)

SafetySafety

Receiving Any Study Receiving Any Study MedicationMedication

1190 (99%)1190 (99%)

Intent to treatIntent to treat

Receiving Study Receiving Study medication and a medication and a Baseline VABaseline VA

1186 (98%)1186 (98%)

Per-protocolPer-protocol

……and without a Major and without a Major Protocol ViolationProtocol Violation

1144 (95%)1144 (95%)

Per Protocol Week 54 Per Protocol Week 54 observedobserved

……and with a Week 54 and with a Week 54 VAVA

1055 (87%)1055 (87%)

Patients withdrawing before treatment

Patients without Baseline VA

No Major Protocol ViolationE.g., CataractE.g., Only a Baseline VA


Ejemplo 2: Incorrecto uso de poblaciones Ejemplo 2: Incorrecto uso de poblaciones (1)(1)

DiseñoDiseño Cirugía vs Tratamiento Médico en estenosis Cirugía vs Tratamiento Médico en estenosis

carotidea bilateral (Sackket et al., 1985)carotidea bilateral (Sackket et al., 1985) Variable principalVariable principal: Número de pacientes que : Número de pacientes que

presenten TIA, ACV o muertepresenten TIA, ACV o muerte Distribución de los pacientes:Distribución de los pacientes:

Pacientes randomizados:Pacientes randomizados: 167167 Tratamiento quirúrgico: Tratamiento quirúrgico: 94 94 Tratamiento médico:Tratamiento médico: 73 73

– Pacientes que no completaron el estudio Pacientes que no completaron el estudio debido a ACV en las fases iniciales de debido a ACV en las fases iniciales de hospitalización: hospitalización: Tratamiento quirúrgico:Tratamiento quirúrgico: 15 pacientes 15 pacientes Tratamiento médico:Tratamiento médico: 01 pacientes 01 pacientes



Población Por Protocolo (PP):Población Por Protocolo (PP):

Pacientes que hayan completado el estudioPacientes que hayan completado el estudio

AnálisisAnálisis

– Tratamiento quirúrgico:Tratamiento quirúrgico: 43 / (94 - 15) = 43 / 79 = 54%43 / (94 - 15) = 43 / 79 = 54%

– Tratamiento médico:Tratamiento médico: 53 / (73 - 1) = 53 / 72 = 74%53 / (73 - 1) = 53 / 72 = 74%

– Reducción del riesgo:Reducción del riesgo:27%, p = 0.0227%, p = 0.02

Primer análisis que se realiza :



El análisis definitivo queda de la siguiente forma :

Población Intención de Tratar (ITT):Población Intención de Tratar (ITT):

Todos los pacientes randomizadosTodos los pacientes randomizados

AnálisisAnálisis– Tratamiento quirúrgico:Tratamiento quirúrgico: 58 / 94 = 62%58 / 94 = 62%– Tratamiento médico:Tratamiento médico: 54 / 73 = 74%54 / 73 = 74%– Reducción del riesgo:Reducción del riesgo:18%, p = 0.0918%, p = 0.09 (PP: 27%, p = (PP: 27%, p =

0.02)0.02)

Conclusiones: La población correcta de análisis es la ITT El tratamiento quirúrgico no ha demostrado ser significativamente superior al tratamiento médico


Relación de los Relación de los valores faltantes convalores faltantes con

1) Tratamiento1) Tratamiento2) Resultado2) Resultado


A B

X X

X X

X X

X X

X X

X X

X X

X X

X X

X X

Effi cacy

A B

X X

X X

X X

X X

X X

X X

X X

. .

. .

. .

Effi cacy

A B

X X

X X

X X

X X

X X

X X

X X

. X

. X

. .

Effi cacy

0%

2%

4%

6%

8%

10%

12%

14%

A B

Obs

MD

0%

10%

20%

30%

40%

50%

60%

A B

Obs

MD

0%

2%

4%

6%

8%

10%

12%

14%

A B

Obs

MD

0%

2%

4%

6%

8%

10%

12%

14%

16%

18%

A B

Obs

MD


Trt Outc.Missing - -

S = 5,0% S = 12,0%

S = - S = - S = - S = -

MissingnessA B

Succes (M.D.)A B

Succes (Observed)A B

n % N %S 5 5,0% 12 12,0%F 95 95,0% 88 88,0%

100 100% 100 100%

% dif -7,0%OR 0,386RR 0,417

A B

A B

X X

X X

X X

X X

X X

X X

X X

X X

X X

X X

Effi cacy

0%

2%

4%

6%

8%

10%

12%

14%

A B

Obs

MD


Trt Outc.Missing - -

S = 5,0% S = 12,0%

S = 30,0% S = 30,0% S = 5,0% S = 12,0%

B BA

Succes (Observed)

Succes (M.D.)MissingnessA

A B

n % N %S 3,5 5,0% 8,4 12,0%F 66,5 95,0% 61,6 88,0%

70 100% 70 100%

% dif -7,0%

OR 0,386

RR 0,417

A B

n % N %S 5 5,0% 12 12,0%F 95 95,0% 88 88,0%

100 100% 100 100%

% dif -7,0%OR 0,386RR 0,417

BA

A B

X X

X X

X X

X X

X X

X X

X X

. .

. .

. .

Effi cacy

0%

2%

4%

6%

8%

10%

12%

14%

A B

Obs

MD


Trt Outc.Missing si _

S = 5,0% S = 12,0%

S = 10,0% S = 30,0% S = 5,0% S = 12,0%

MissingnessA B

Succes (Observed)

Succes (M.D.)

BA

A B

n % N %S 4,5 5,0% 8,4 12,0%F 85,5 95,0% 61,6 88,0%

90 100% 70 100%

% dif -7,0%OR 0,386RR 0,417

A B

n % N %

S 5 5,0% 12 12,0%F 95 95,0% 88 88,0%

100 100% 100 100%

% dif -7,0%OR 0,386RR 0,417

A B

A B

X X

X X

X X

X X

X X

X X

X X

. X

. X

. .

Effi cacy

0%

2%

4%

6%

8%

10%

12%

14%

A B

Obs

MD


0%

2%

4%

6%

8%

10%

12%

14%

16%

18%

A B

Obs

MDA B

X X

X X

X X

X X

X X

X X

X X

. .

. .

. .

Effi cacy

Trt Outc.Missing - si

S = 5,0% S = 12,0%

S = 30,0% S = 30,0% S = 10,0% S = 17,0%

MissingnessA B

Succes (Observed)A B

Succes (M.D.)A B

n % N %S 3,5 5,0% 8,4 12,0%F 66,5 95,0% 61,6 88,0%

70 100% 70 100%

% dif -7,0%OR 0,386RR 0,417

A B

n % N %S 6,5 6,5% 13,5 13,5%F 93,5 93,5% 86,5 86,5%

100 100% 100 100%

% dif -7,0%OR 0,445RR 0,481

A B


Trt Outc.Missing - si

S = 5,0% S = 12,0%

S = 30,0% S = 30,0% S = 50,0% S = 50,0%

Missingness

Succes (Observed)

Succes (M.D.)

A B

A B A B

n % N %S 3,5 5,0% 8,4 12,0%F 66,5 95,0% 61,6 88,0%

70 100% 70 100%

% dif -7,0%OR 0,386RR 0,417

A B

n % N %S 18,5 18,5% 23,4 23,4%F 81,5 81,5% 76,6 76,6%

100 100% 100 100%

% dif -4,9%OR 0,743RR 0,791

A B

A B

X X

X X

X X

X X

X X

X X

X X

. .

. .

. .

Effi cacy

0%

10%

20%

30%

40%

50%

60%

A B

Obs

MD


Trt Outc.Missing si si

S = 5.0% S = 12.0%

S = 30.0% S = 10.0% S = 50.0% S = 50.0%

MissingnessA B

A

A B

BObserved

Succes (M.D.)

n % N %S 4,5 5,0% 8,4 12,0%F 85,5 95,0% 61,6 88,0%

90 100% 70 100%

% dif -7,0%

OR 0,386RR 0,417

A BA B

X X

X X

X X

X X

X X

X X

X X

. X

. X

. .

Effi cacy

0%

10%

20%

30%

40%

50%

60%

A B

Obs

MD

n % N %S 18.5 18.5% 15.8 15.8%F 81.5 81.5% 84.2 84.2%

100 100% 100 100%

% dif 3%OR 1.210RR 1.171

A B


Tipos de MissingTipos de Missing


MCARMCAR

– Missing completely at randomMissing completely at random

La probabilidad de obtener un missing es La probabilidad de obtener un missing es completamente independiente de:completamente independiente de:– Valores observados:Valores observados:

Variables basales, otras mediciones de la misma Variables basales, otras mediciones de la misma variable...variable...

– Valores no observados o missingValores no observados o missing

Ejemplo: Cambio de ubicación geográficaEjemplo: Cambio de ubicación geográfica


MARMAR

– Missing at randomMissing at random

La probabilidad de obtener un La probabilidad de obtener un missing depende:missing depende:– Sí: Valores observados:Sí: Valores observados:– No: Valores no observados o missingNo: Valores no observados o missing

Ejemplo: Sujetos con peor puntuación basal Ejemplo: Sujetos con peor puntuación basal abandonan el estudio independientemente abandonan el estudio independientemente del resultadodel resultado


Non-IgnorableNon-Ignorable

La probabilidad de obtener un La probabilidad de obtener un missing depende:missing depende:– Valores no observados o missingValores no observados o missing

– Ejemplo: malas o excelentes respuestas cursan Ejemplo: malas o excelentes respuestas cursan con una mayor tasa de abandonoscon una mayor tasa de abandonos


Manejo de los Manejo de los valores faltantesvalores faltantes


General StrategiesGeneral Strategies

Complete-case analysisComplete-case analysis ““Weigthing methods”Weigthing methods” Imputation methodsImputation methods Analysing data as incompleteAnalysing data as incomplete Other methodsOther methods


Complete-case analysisComplete-case analysis

Analyse only subjects with complete Analyse only subjects with complete datadata

Problems:Problems:– Loss of powerLoss of power– BiasBias

Only if MCAR may be assumedOnly if MCAR may be assumedAgainst the ITT principleAgainst the ITT principle


““Weigthing methods”Weigthing methods”(Sometimes considered as a form of imputation)(Sometimes considered as a form of imputation)

To constuct weigths for incomplete To constuct weigths for incomplete cases:cases:– Each patient belongs to a subgroup in Each patient belongs to a subgroup in

which all subjects have the same which all subjects have the same characteristicscharacteristics

– A proportion within each subgroup are A proportion within each subgroup are destined to complete the studydestined to complete the study

Heyting el al.Heyting el al. Robins et al.Robins et al.


Datos faltantes : métodos de tratamiento Datos faltantes : métodos de tratamiento (2)(2)

Paciente Visita basal Visita 1 Visita 2 Visita 3 Visita 4

0010 75 72 60 55

0005 76 78

0101 80 70 66

0201 81 75 75 78 80

0060 78

RandomizaciónInicio del tratamiento

Sujetos con valores missing en la variable de eficacia



Se aplica el método LOCF (Last Observation Carried Forward)


0010 75 72 72 60 55

0005 76 78 78 78 78

0101 80 70 66

0201 81 75 75 78 80

0060 78 Excluido de las poblaciones ITT y PP




Se aplica el método BOCF (Basal Observation Carried Forward)


0010 75 72 72 60 55

0005 76 78 78 78 78

0101 80 80 80 70 66

0201 81 75 75 78 80

0060 78 78 78 78 78



Ejemplo: LOCF & Extrapolación lineal

Adas-Cog36

32

28

24-

20

16

12

8

4

0 2 4 6 8 10 12 14 16 18

Time month

LOCF =

REGRESIÓN LINEAL

Sesgo de la

información


Imputation methodsImputation methods

LOCF and variantsLOCF and variants– Bias: Bias:

depending on the amount and timing of drop-outs:depending on the amount and timing of drop-outs: Ej: The conditions under study has a worsening Ej: The conditions under study has a worsening

coursecourse– Conservative: Conservative:

Drop-outs beacuse of lack of efficacy in the control Drop-outs beacuse of lack of efficacy in the control groupgroup

– Anticonservative:Anticonservative: Drop-outs beacuse of intolerance in the test groupDrop-outs beacuse of intolerance in the test group

– Otros: interpolación, extrapolaciónOtros: interpolación, extrapolación


Adas-Cog36

32

28

24-

20

16

12

8

4

0 2 4 6 8 10 12 14 16 18

Time month

Ejemplo: falta el resultado de Adas-cog en alguno de los tiempos

Imputación por regresión


Imputation methodsImputation methods

Worst case analysis:Worst case analysis:– Impute:Impute:

The worst response to the testThe worst response to the testThe best response to the controlThe best response to the control

– Ultraconservative. Increases the variability.Ultraconservative. Increases the variability.– Robustness of results:Robustness of results:

Second approach: “Sensitivity analysis”Second approach: “Sensitivity analysis” Lower bound of efficacyLower bound of efficacy


Group MeansGroup Means

CContinuous variableontinuous variable:: – group mean derived from a grouping group mean derived from a grouping

variablevariable

CCategoricalategorical – ordinal variable: – ordinal variable:– ModeMode– If If no unique modeno unique mode::

– NominalNominal: : a value will be randomly selecteda value will be randomly selected– OOrdinalrdinal: : the ‘middle’ category or a value is the ‘middle’ category or a value is

randomly chosen from the middle tworandomly chosen from the middle two (even case) (even case)


Predicted MeanPredicted Mean

CContinuous or ordinalontinuous or ordinal variables: variables:LLeast-squares multiple regression algorithm east-squares multiple regression algorithm

to impute the most likely value to impute the most likely value

BBinary or categorical variableinary or categorical variable::a discriminant method is applied to impute a discriminant method is applied to impute

the most likely value.the most likely value.


Imputation Class methodsImputation Class methods Imputed values from responders that are Imputed values from responders that are

similar with respect to a set of auxiliary similar with respect to a set of auxiliary variables.variables.– Clinical experienceClinical experience– Statistical methods: Statistical methods: Hot-DeckingHot-Decking

RRespondents and non-respondents espondents and non-respondents are sorted are sorted into a into a number of imputation subsets according to a user-number of imputation subsets according to a user-specified set of covariates. specified set of covariates.

An imputation sub-set comprises cases with the same An imputation sub-set comprises cases with the same values as those of the user-specified covariates. values as those of the user-specified covariates.

Missing values are then replaced with values taken Missing values are then replaced with values taken from matching respondents. from matching respondents.

– Options:Options: The first respondent’s valueThe first respondent’s value (similar in time) (similar in time) A respondent’s randomly selectedA respondent’s randomly selected valuevalue


Multiple ImputationMultiple Imputation

RReplaces each missing value in the eplaces each missing value in the dataset with several imputed values dataset with several imputed values instead of just one. instead of just one. Rubin 1970's Rubin 1970's

Steps:Steps:Use complete data to estimateUse complete data to estimateCombine the estimators Combine the estimators (i.e. Regresion (i.e. Regresion

coefficients)coefficients) to compute predicted values to compute predicted valuesRandomly simulate a set of residuals to be Randomly simulate a set of residuals to be

added to the regression to impute m valuesadded to the regression to impute m values


MI: Assumptions MI: Assumptions (2)(2)

The data model:The data model:– Probability model on observed dataProbability model on observed data

– Multivariate normal, loglinear ...Multivariate normal, loglinear ...Prediction of the missing dataPrediction of the missing data

The distributionThe distributionSpecification of the distribution for the Specification of the distribution for the

parameters of the imputation modelsparameters of the imputation models– Use likelihood / bayesian techniques for analysisUse likelihood / bayesian techniques for analysis

Noninformative prior distributionNoninformative prior distribution

The mechanism of nonresponseThe mechanism of nonresponse


Multiple ImputationMultiple Imputation

S-PLUSS-PLUS SOLASSOLAS Gary King: Gary King:

AmeliaAmelia

Joe Schafer: Joe Schafer: webweb SoftSoft TheThe multiplemultiple imputationimputation FAQ FAQ pagepage


Analysing data as Analysing data as incompleteincomplete

Time to event variablesTime to event variables Mixed models (random-fixed)Mixed models (random-fixed)


OtherOther

Gould 1980Gould 1980– Converts the variable into an ordinal score. Converts the variable into an ordinal score. – Impute according a pre-defined value (ej. Impute according a pre-defined value (ej.

percentile) and the time and cause of drop-out percentile) and the time and cause of drop-out (lack of efficacy, cure, adverse effects...)(lack of efficacy, cure, adverse effects...)

Miscelanea: Miscelanea: Missing data indicators, pairwise deletion...Missing data indicators, pairwise deletion...


Missing Data in Missing Data in Clinical Trials –Clinical Trials –

A Regulatory ViewA Regulatory View


ICH-E3,6,9ICH-E3,6,9

Key points:Key points:– Potential source of biasPotential source of bias– Common in Clinical TrialsCommon in Clinical Trials– Avoiding MDAvoiding MD– Importance of the methods of dealingImportance of the methods of dealing– Pre-specification, re-definitionPre-specification, re-definition– Lack of universally accepted method for Lack of universally accepted method for

handlinghandling– Sensitivity analysisSensitivity analysis– Identification and description of missingnessIdentification and description of missingness


Points to Consider on Points to Consider on Biostatistical / Biostatistical /

Methodological issues Methodological issues arising from recent CPMP arising from recent CPMP

discussion on licensing discussion on licensing applicationsapplications

PtC on Missing DataPtC on Missing Data


StructureStructure

1.1. IntroductionIntroduction

2.2. The effect of MD on data analysisThe effect of MD on data analysis

3.3. Handling of MDHandling of MD

4.4. General recommendationsGeneral recommendations


INTRODUCTION


IntroductionIntroduction

Potential source of biasPotential source of bias

Many possible sources and different Many possible sources and different

degrees of incompletenessdegrees of incompleteness

MD violates the ITT principle:MD violates the ITT principle:– Full set analysis requires imputationFull set analysis requires imputation

The strategy employed might in itself The strategy employed might in itself

provide a source of biasprovide a source of bias


The effect of missing values on data analysis and

interpretation


Effect on data analysis Effect on data analysis (1)(1)

Power:Power:– Reduction of cases for analysis: Reduction of cases for analysis:

reduction of powerreduction of power

Variability:Variability:– Non-completers (greater likelihood of Non-completers (greater likelihood of

extreme values):extreme values):Their loss => underestimate of variabilityTheir loss => underestimate of variability


Effect on data analysis Effect on data analysis (2)(2)

Bias:Bias: Estimation of treatment effectEstimation of treatment effect Comparability of treatment groupsComparability of treatment groups Representativeness of the sampleRepresentativeness of the sample

– TThe reduction of the statistical power is mainly related to he reduction of the statistical power is mainly related to the number of missing valuesthe number of missing values

– TThe risk of bias depends upon the relationship betweenhe risk of bias depends upon the relationship between:: MissingnessMissingness TTreatmentreatment OOutcomeutcome


Effect on data analysis Effect on data analysis ((33))

NotNot expected to lead to bias: expected to lead to bias:– if if MDMD are are only relatedonly related to the to the

treatmenttreatment – (an observation is more likely to be missing on (an observation is more likely to be missing on

one treatment arm than another) one treatment arm than another)

– but but not not to the to the outcomeoutcome – real value of the unobserved measurement (poor real value of the unobserved measurement (poor

outcomes are no more likely to be missing than outcomes are no more likely to be missing than good outcomes).good outcomes).



Bias:Bias:– if if MD MD ((unmeasured observationunmeasured observations)s) areare

related to related to the real value of the the real value of the outcomeoutcome(e.g. the unobserved measurements have an (e.g. the unobserved measurements have an

higher proportion of poor outcomes)higher proportion of poor outcomes)– this will lead to bias even if the missing values are this will lead to bias even if the missing values are

not related to treatment (i.e. missing values are not related to treatment (i.e. missing values are equally likely in all treatment arms).equally likely in all treatment arms).



Bias:Bias:

– If If MDMD if they are if they are related to bothrelated to both the the treatmenttreatment and the unobserved and the unobserved outcomeoutcome variable variable (e.g. missing values are more likely in one (e.g. missing values are more likely in one

treatment arm because it is not as effective). treatment arm because it is not as effective).



Pragmatic approach:Pragmatic approach:– In most cases it is difficult or impossible to In most cases it is difficult or impossible to

elucidate whether the relationship elucidate whether the relationship between missing values and the between missing values and the unobserved outcome variable is unobserved outcome variable is completely absent. completely absent.

– Thus it is sensible to adopt a conservative Thus it is sensible to adopt a conservative approach, considering missing values as a approach, considering missing values as a potential source of bias.potential source of bias.


Handling of MD


Handling of MD Handling of MD (1)(1)

Avoidance of missingness:Avoidance of missingness:– In the design and conduct of a clinical trial all In the design and conduct of a clinical trial all

efforts should be directed towards minimising efforts should be directed towards minimising the amount of missing data likely to occur. the amount of missing data likely to occur.

– Despite these efforts some missing values will Despite these efforts some missing values will generally be expected. generally be expected.

The way these missing observations are The way these missing observations are handled may substantially affect the handled may substantially affect the conclusions of the study.conclusions of the study.


Handling of MD Handling of MD ((22))

Complete case analysis:Complete case analysis:– Bias, power and variabilityBias, power and variability– Not generally appropriate. Exceptions:Not generally appropriate. Exceptions:

– Exploratory studiesExploratory studies, , especially in the initial phases especially in the initial phases of drug development.of drug development.

– Secondary supportive analysis in confirmatory Secondary supportive analysis in confirmatory trials (robustness)trials (robustness)

Violates the ITT principle.Violates the ITT principle. It cIt cannot be recommended as the primary annot be recommended as the primary

analysis in a confirmatory trialanalysis in a confirmatory trial



Imputation of Missing Data:Imputation of Missing Data:– Scope of imputation:Scope of imputation:

Not restricted to main outcomes: Not restricted to main outcomes: – (secondary efficacy, safety, baseline covariates...)(secondary efficacy, safety, baseline covariates...)

– Methods for imputation:Methods for imputation:Many techniquesMany techniquesNo gold standard for every situationNo gold standard for every situation



Methods for imputation Methods for imputation (cont)(cont)::– Not a description of the different Not a description of the different

methodsmethods– All methods may be valid:All methods may be valid:

Simple methods to more complex:Simple methods to more complex:– From LOCF to multiple imputation methodsFrom LOCF to multiple imputation methods

But their appropriateness has to be justifiedBut their appropriateness has to be justified– e.g.: LOCF: e.g.: LOCF: acceptable if measurements are acceptable if measurements are

expected to be relatively constant over time. expected to be relatively constant over time. In In Alzheimer’s disease where the patient’s Alzheimer’s disease where the patient’s

condition is expected to deteriorate over time, condition is expected to deteriorate over time, the the LOCF LOCF method is less acceptablemethod is less acceptable



Statistical approaches less sensitive to MDStatistical approaches less sensitive to MD::

– Mixed modelsMixed models– Survival modelsSurvival models

They assume no relationship between treatment and They assume no relationship between treatment and the missing outcome, and generally this cannot be the missing outcome, and generally this cannot be assumed.assumed.


General recommendations


General recommendations General recommendations (1)(1)

Avoidance of missing dataAvoidance of missing data– Try to reduce the number of MDTry to reduce the number of MD

Anticipate sources and try to avoid them in the Anticipate sources and try to avoid them in the designdesign

Strategies to obtain measurements Strategies to obtain measurements If large amount of MD is expected:If large amount of MD is expected:

– Relevance of blinding (assignment and evaluation)Relevance of blinding (assignment and evaluation)Anticipation of the “acceptable amount of MD”Anticipation of the “acceptable amount of MD”

– Sample sizeSample size



Avoidance of missing data Avoidance of missing data (cont)(cont)

– ““Acceptable amount” of MD:Acceptable amount” of MD:Not general rule, depends onNot general rule, depends on

– Nature of variableNature of variable Mortality vs sophisticated methods of diagnosisMortality vs sophisticated methods of diagnosis

– Length of the clinical trialLength of the clinical trial– Condition under studyCondition under study

Psychiatric disorders: low adherence of patients Psychiatric disorders: low adherence of patients to sto sttudy protocoludy protocol



Avoidance of missing data Avoidance of missing data (cont)(cont)

– Continue data collection after patient Continue data collection after patient withdrawalwithdrawal ITT based on real dataITT based on real data

– AlternativesAlternatives Analysis on incomplete dataAnalysis on incomplete data

oror Analysis on imputed dataAnalysis on imputed data



Design of the study. Design of the study. Relevance of predefinitionRelevance of predefinition

– Pre-specify in the protocol:Pre-specify in the protocol:Description and justification of the methodDescription and justification of the methodAnticipation of the expected amount of MDAnticipation of the expected amount of MD

– Deviations documented and justifiedDeviations documented and justifiedConservative:Conservative:

– To avoid:To avoid: mminimisation of differences in non-inferiority trials, inimisation of differences in non-inferiority trials,

overestimation in superiority trialsoverestimation in superiority trials



Design of the study. Design of the study. Relevance of predefinitionRelevance of predefinition (cont)(cont)

– Update:Update:– Unpredictability of some problemsUnpredictability of some problems

Statistical Analysis PlanStatistical Analysis PlanDuring the Blind ReviewDuring the Blind Review

– Deviation and amendments documented (traceability)Deviation and amendments documented (traceability)– Identification of the blindinIdentification of the blindingg


General recommendations General recommendations ((66))

Analysis of missing dataAnalysis of missing data– Pattern of MD: time and proportion Pattern of MD: time and proportion

Investigate Investigate whether there is any indication whether there is any indication of of differdifferencesences between the treatment groups. between the treatment groups.

– Elucidate if pElucidate if patients with and without missing atients with and without missing values have different characteristics at baselinevalues have different characteristics at baseline..

This might help to establish:This might help to establish:– whether the missing values have lead towhether the missing values have lead to baseline baseline

imbalanceimbalance, and , and – whether the process generating missing values has whether the process generating missing values has

differentially influenced the treatment groups. differentially influenced the treatment groups.



Sensitivity analysisSensitivity analysis a set of analyses showing the influence of different a set of analyses showing the influence of different

methods of handling missing data on the study resultsmethods of handling missing data on the study results

– Some examples:Some examples: Imputation of Best plausible vs Worst plausibleImputation of Best plausible vs Worst plausible Best possible in control and Worst possible in experimental Best possible in control and Worst possible in experimental

and inverselyand inversely Full set analysis vs complete case analysisFull set analysis vs complete case analysis

– Pre-defined and designed to assess the Pre-defined and designed to assess the repercussion on the results of the particular repercussion on the results of the particular assumptions made in imputationassumptions made in imputation



Final ReportFinal Report– Detailed description of the planned and Detailed description of the planned and

amendments of the predefined methods amendments of the predefined methods

– Discussion of the MD:Discussion of the MD: Number, Time & PatternNumber, Time & Pattern Possible implications in efficacy and safetyPossible implications in efficacy and safety

– Imputed values must be listed and identifiedImputed values must be listed and identified

– A sensitivity analysis may give robustness to the A sensitivity analysis may give robustness to the conclusionsconclusions

feb-2007 [email protected] 1 cpmp/ewp/1776/99: ptc on missing data

Documents

tratamiento mdicorelacin

distribucin de pacientes

nmero de pacientes

incorrecto uso de poblaciones

pacientestratamiento

descripcin de poblaciones

per protocol week

ms relacionados